MR metabolomics of fecal extracts: applications in the study of bowel diseases.
about
Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique.Metabonomics based NMR in Crohn's disease applying PLS-DAFecal metabolomics: assay performance and association with colorectal cancer.Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial.Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkersMetabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individualsMetabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis.NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.Noninvasive metabolic profiling for painless diagnosis of human diseases and disorders.Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology.NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.Functional metagenomic investigations of the human intestinal microbiota.Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomics1H NMR based metabolic profiling in Crohn's disease by random forest methodology.Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.In vitro analysis of the impact of enrofloxacin residues on the human intestinal microbiota using H-NMR spectroscopy.In vitro fermentation of potential prebiotic flours from natural sources: impact on the human colonic microbiota and metabolomeA Metabolomics Approach to Pharmacotherapy Personalization
P2860
Q30571181-3D8337C1-46AF-4D4C-808F-09F627A09E85Q33596759-1DBDFB12-9C02-4B8C-A9B1-BD67EC887610Q34096850-7BC9C4E2-3B7D-4131-928E-D207656C610CQ34524952-9A950BDA-353F-49E8-B78A-71212AE36F59Q34855915-8BBE8D34-C2B3-423C-8AB1-4A9865DD1D6FQ34900690-697F5B90-5A08-4F9E-A9D0-0BFD90E96417Q36570929-20BDE87A-5F23-4DC6-8127-64AA8EAE3F8DQ37023883-0E5F7C0D-CF12-466D-A4A6-F280AF9C7939Q37301856-BE9AA9A1-35C6-4DF9-B665-C03956B79CDBQ37474509-E802DDE2-95AB-4525-916E-18E90DE3F639Q37989165-BC193747-B07E-4E07-9E15-E4591E3C6434Q38119451-AE47A9F6-42BE-4A6E-AC4A-C145003D3A65Q38212243-5EE65A70-DF08-4B95-9813-1B226F9CEA39Q38729839-9B5CB20C-E639-4D0A-884D-78DC630F6201Q41305034-F43E7AFD-D2CA-480C-B6BE-36C2B9D81883Q46964998-F9CADAD2-895A-4B56-BC9E-0178F8528A85Q51598103-09F09806-BA05-46F0-BE5D-628B45F1248FQ54321548-5F3E47E0-80AB-403A-B7B9-6B6CD18E7281Q56981031-E99D6B4D-1049-41CD-B69F-7F0584561FE1Q58762484-3792B83D-6EA9-4283-9401-690C0D367EAD
P2860
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
@en
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
@nl
type
label
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
@en
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
@nl
prefLabel
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
@en
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
@nl
P2093
P356
P1476
MR metabolomics of fecal extracts: applications in the study of bowel diseases.
@en
P2093
Ian C P Smith
Ray L Somorjai
Tedros Bezabeh
P304
P356
10.1002/MRC.2530
P478
47 Suppl 1
P577
2009-12-01T00:00:00Z